Amid mounting concerns over the new 'XE' variant of Covid and a day after the Brihanmumbai Municipal Corporation reported its first case in Mumbai, Maharashtra Health Minister Rajesh Tope on Thursday said the state health department has not received any confirmation about the variant and thus cannot confirm it.
The Omicron variant of Covid-19 adds new uncertainties to the global economic outlook but much will depend on its speed of transmission, hospitalisation and death rates, and also the effectiveness of vaccines, Moody's Analytics said on Monday. In its commentary titled 'Much to Learn About Omicronast', Moody's Analytics said although the variant appears to spread "remarkably quickly", it will be at least two more weeks before more will be known about this new variant. "The Omicron variant of COVID-19 adds new measures of uncertainty to the outlook for the global economy, although it is too soon to adequately quantify that risk.
The patients were being administered paracetamol, and not Remdesivir drug, which was used for patients in the first and second COVID-19 waves, they said.
Union health secretary Rajesh Bhushan held a review meeting with states and Union Territories on Tuesday and advised them to ramp up testing for early identification and management of cases.
Section 144 of CrPC has been imposed in Mumbai for December 11 and 12, prohibiting rallies, morchas, processions etc of persons and vehicles.
According to the people aware of the matter, there are currently 10 different variants of COVID-19 in the country, with the latest being BF.7.
Foreign ministry spokesperson Mao Ning went on the offensive saying "we do not believe the entry restriction measures some countries have taken against China are science-based".
A 39-year-old Chandigarh resident who had returned from South Africa a few days ago tested positive for COVID-19 on Monday and his sample will now be sent to Delhi for whole genome sequencing.
China on Wednesday reported cases of an Omicron subvariant surfacing in Beijing and Shaanxi province as the Chinese capital announced new measures, making it mandatory to show proof of vaccination for people entering public places.
"Protocol is very clear. Once any international traveller test positive, apart from following the routine protocol of containment and treatment, we are sending their samples to genome sequencing," said Mallikarjuna.
These 51 cases were detected from over 45,000 samples sequenced so far in the country.
In view of a new contagious variant of COVID-19 being found in South Africa, Mumbai Mayor Kishori Pednekar on Saturday said that all the passengers coming to the city from that country will be quarantined.
"As of now, there is no data from any country to suggest these new subvariants are more clinically severe," Chief scientist at WHO clarified.
While virologists say theoretically the vaccine that works on Delta should work on the Delta Plus variant as well, more research is needed.
The weekly epidemiological update by WHO revealed the week of December 20-26 saw the global number of new COVID-19 cases increase by 11 per cent as compared to the previous week.
The UK's health authorities have confirmed that a new and "most significant" variant of COVID-19 is officially under investigation in the country as the government on Friday added six countries to its travel ban red list from southern Africa, where B.1.1.529 strain was first identified.
Six cases of the new COVID-19 Omicron variant have been identified in Scotland on Monday, taking the UK's total to nine following three cases detected in England earlier.
'An RT-PCR test will be conducted after seven days and necessary steps will be taken accordingly'
People must be vigilant, follow all safety norms and not let a sense of complacency set in, several doctors said a day after the positivity rate in the city was --- the highest in two months.
It is not confirmed whether the patient was carrying the Omicron variant of coronavirus, which was identified as the variant of concern by the WHO, the official said.
In his fresh directive, Xi said that more targeted patriotic health campaigns should be conducted as the country's COVID-19 epidemic prevention and control faces new situations and new tasks.
With Omicron, the new variant of SARS-CoV2, the third wave of coronavirus could hit the peak by February with cases likely to be reaching up to 1-1.5 lakh a day in the country, but it will be milder than the second wave, Manindra Agarwal, IIT scientist involved in the mathematical projection of trajectory of COVID-19, said.
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both.
The renowned pulmonologist, who was part of the national COVID task force, highlighted the need for research on developing vaccines which will cover not only the current circulating strains but also from the emerging variants.
Union Minister for Youth Affairs and Sports Anurag Thakur said the Board of Control for Cricket in India should consult the government before sending the cricket team to South Africa, where a new COVID-19 variant is causing havoc.
After a long hiatus of more than 20 months, the government had on November 26 announced the resumption of scheduled international commercial flights from December 15.
The presence of spike protein facilitates a virus' entry into the host cell and is responsible for making it transmissible and causing infection.
If two individuals in an indoor space are not wearing a mask, in just 10 minutes, the infected person can transmit the virus to the other person, while if both are wearing a fitted N-95 mask, it requires over 600 hours of exposure for transmission, he said.
The UK on Saturday detected two cases of the new COVID-19 variant, Omicron, according to health secretary Sajid Javid as he added four more African countries to Britain's travel red list.
Gates, 66, on Tuesday, said that "I know it's frustrating to go into another holiday season with COVID looming over us. But it won't be like this forever. Someday the pandemic will end, and the better we look after each other, the sooner that time will come."
The Serum Institute of India is the first Indian company to seek approval for the COVID-19 booster dose.
This comes amid the rising concerns of the new COVID-19 variant 'Omicron' which is being reported by foreign countries.
Chief Minister Uddhav Thackeray has instructed officials to take extra efforts to complete the administration of the second dose of anti-COVID-19 vaccines to all eligible people.
However, the severity of illness is likely to be much lower, according to a study.
Two doses of Pfizer and AstraZeneca COVID-19 vaccines generate lower levels of antibodies against the Omicron variant of coronavirus, according to a study which suggests that those previously infected or vaccinated may be at an increased risk of infection.
Booster doses of COVID-19 vaccines are the easiest barrier that must be created immediately against Omicron, according to eminent virologist Dr T Jacob John, who noted that it may not seed the third wave of the pandemic, but breakthrough infections may be common due to the new variant.
With 100 days until the start of the Winter Olympics, Beijing is promising a "simple and safe" 2022 Games - although preparations are anything but simple as China readies to host thousands of athletes and personnel as it battles COVID-19 flare-ups.
The Covid-19 vaccine demonstrated an overall 90.4 per cent efficacy in phase 3 clinical trials, reports Sohini Das
The Union health ministry on Friday said while there is no evidence to suggest that existing vaccines do not work on the Omicron variant of SARS-CoV-2, some of the mutations reported may decrease the efficacy of the jabs.
South Africa will remain on the lowest 'level 1' of its five-level lockdown strategy to fight the COVID-19 pandemic despite the global panic around the detection of the Omicron variant in the country, President Cyril Ramaphosa has announced .
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances